Clinical Study

Acute Severe Anaphylaxis in Nepali Patients with Neurotoxic Snakebite Envenoming Treated with the VINS Polyvalent Antivenom

Table 2

Details of the clinical events in 13 neurotoxically envenomed patients with postantivenom serious adverse events.

Patient NS D0AVRCR arrestShockHypotensionSBDyspnoeaWheezeCyanosisCough NSFrothy secretionsP RespLOVAPRestlessDrowsyVomitingRashSoft tissue oedemaFeverTotalOutcome

132H1-------21--11-11--8D
122H2--21-------11-1--8D
112L----1------1----11-4D
102H11--------------1115D
92L11--1-----------1--4D
82H1--111--11-----11--8D
73H2--11------------4D
63H1-11----1-1--------5D
52H--1-11----------1--4R
44H----111------1-----4R
34L--1-1-----------1--3R
21H-1-------------11-14R
14L-------1---1----1--3R

Total

9335831142121313102264

NS D0: neurotoxicity score on Day 0 (baseline); AVR: antivenom regimen; H: high-dose antivenom regimen; L: low-dose antivenom regimen; CR: cardiorespiratory; SB: sinus bradycardia.
P Resp: paradoxical respiration; LO: laryngeal oedema; VAP: ventilator associated pneumonia; D: died; R: resolved.
: unilateral lower eyelid swelling.
: recorded as angioedema, exact anatomical location unknown.